TUCSON
520.748.4400
About Us
Professional Staff
Board of Directors
Careers
Contact Us
Frederick Gardner
Cottrell Foundation
Successes
Ventures
Biotechnology
Medical Devices
Other
Historic Investments
Technologies
The CH2 Domain Scaffold – ABDURINS™
Deimmunized Sarcin Ribotoxin
Endotoxin-free ClearColi™ Expression System
Fibronectin Artificial Antibody Scaffold
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
Pichia Classic Expression Platform
Pichia GlyoSwitch™ Protein Expression System
Ultrasound Tissue Harmonic Imaging
VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
Innovate With Us
News & Events
Home
»
News & Events
»
2024
MedTech Innovator Selected to Lead the Enabling Technologies Hub in the Next Generation of the BARDA Accelerator Network
9.18.2024
Translational Drug Development (TD2) Expands Clinical Trial Services into Europe
9.4.2024
Top 20 Life Sciences Companies Named to BioTools Innovator 2024 Cohort
5.29.2024
Pheon Therapeutics announces $120m Series B financing to fund ADC pipeline
5.21.2024
Particle Dynamics Appoints New CFO as it Advances its Strategic Growth Plans
4.23.2024
Elizabeth Hickman to Succeed Tim Scott as AustinPx CEO
3.6.2024
Complete Genomics and seqWell Announce Codevelopment Partnership
2.9.2024
TD2 Expands Preclinical and Clinical Services by Acquiring Flow Contract Site Laboratory (FCSL)
2.1.2024
AustinPx Partners with Microsize on KinetiSol® Technology
2.1.2024
S2 Genomics Raises Series A Round Led by RCT and BroadOak
1.24.2024
News by Year
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
From concept
to market
Innovate with us ›